ConductScience.org, home
Papers
API referenceFor AI assistants

Paper322771

[Long-term therapy using horse anti-dog lymphocyte globulin without sensitization against horse protein].

Scheel J and 5 others. Blut, 1977. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. [Long-term therapy using horse anti-dog lymphocyte globulin without sensitization against horse protein]. Papers, record 322771. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/322771

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[Long-term therapy using horse anti-dog lymphocyte globulin without sensitization against horse protein].
PubMed
Journal
Blut
PubMed
Year
1977
PubMed
Publication types
English Abstract, Journal Article
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0
iCite
Revised in PubMed
2026-10-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Scheel JJ
2Duswald KHK H
3Ring JJ
4Seifert JJ
5Scholz SS
6Brendel WW

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antilymphocyte SerumMajor topic
Animals
Carnivora
Dogs
Drug Hypersensitivity
Female
Horses
Immunoglobulin G
Lymphopenia
Male
Prednisolone
Skin Transplantation
Time Factors
Transplantation, Heterologous

Source PubMed

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,106,338Induction of tolerance to horse gamma globulin (HoGG) and antilymphocyte globulin (HoALG) in humans and experimental animals.Transplant Proc1971https://conductscience.org/library/papers/4106338PubMed
21,237,376Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response.Clin Exp Immunol1975https://conductscience.org/library/papers/1237376PubMed
34,183,661The preparation and properties of anti-lymphocytic sera.Prog Surg1969https://conductscience.org/library/papers/4183661PubMed
44,189,240Immunosuppressive effects of heterologous antilymphocyte serum in monkeys.Lancet1970https://conductscience.org/library/papers/4189240PubMed
54,597,227Renal homotransplantation. I.Curr Probl Surg1974https://conductscience.org/library/papers/4597227PubMed
6790,497[Long-term graft survival in the xenogeneic system wolf-dog (author's transl)].Res Exp Med (Berl)1976https://conductscience.org/library/papers/790497PubMed
75,584,706[Preparation and effect of heterologous anti-dog lymphocyte serums].Z Gesamte Exp Med Einschl Exp Chir1967https://conductscience.org/library/papers/5584706PubMed
814,224,412INDUCTION OF IMMUNOLOGICAL PARALYSIS IN TWO ZONES OF DOSAGE.Proc R Soc Lond B Biol Sci1964https://conductscience.org/library/papers/14224412PubMed
9797,668Improved compatibility of ALG therapy by application of aggregate free globulin.Int Arch Allergy Appl Immunol1976https://conductscience.org/library/papers/797668PubMed
104,110,383Cyclophosphamide-induced tolerance to equine -globulin and to equine antimouse thymocyte globulin in adult mice. II. Resulting prolongation of cardiac allografts in ATG-treated animals.Transplantation1972https://conductscience.org/library/papers/4110383PubMed
114,869,606Antiserum to lymphocytes: interactions with chemical immunosuppressants.Science1968https://conductscience.org/library/papers/4869606PubMed
121,092,538[Incompatibility reactions following foreign serum therapy and their prevention].Dtsch Med Wochenschr1975https://conductscience.org/library/papers/1092538PubMed
1314,482,809Diffusion-in-gel methods for immunological analysis. II.Prog Allergy1962https://conductscience.org/library/papers/14482809PubMed
14809,676[The clinical use of antilymphocyte globulin (ALG) (author's transl)].MMW Munch Med Wochenschr1975https://conductscience.org/library/papers/809676PubMed
154,860,751Further experiments on the action of antilymphocytic antiserum.Proc Natl Acad Sci U S A1967https://conductscience.org/library/papers/4860751PubMed
164,937,967Induction of tolerance to antilymphocyte globulin in man.Transplant Proc1971https://conductscience.org/library/papers/4937967PubMed
174,363,833Specific unresponsiveness to skin allografts in mice. 3. Synergistic effect of tissue extracts, Bordetella pertussis, and antilymphocytic serum.Transplantation1974https://conductscience.org/library/papers/4363833PubMed
1862,375Cumulation and elimination of horse-anti-dog lymphocyte and normal horse gammaglobulin in dogs.Res Exp Med (Berl)1976https://conductscience.org/library/papers/62375PubMed
194,272,899Serology and genetics of the DL-A system. I. Establishment of specificities.Tissue Antigens1973https://conductscience.org/library/papers/4272899PubMed
204,980,325Anti-lymphocytic antibody and autoimmune disease: a review.Clin Exp Immunol1969https://conductscience.org/library/papers/4980325PubMed

See all 28 references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/322771

GET https://conductscience.org/api/papers/v1/322771/references?page=2

API referenceFor AI assistants